These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 23786779

  • 1. Managing bleeding in anticoagulated patients in the emergency care setting.
    Pollack CV.
    J Emerg Med; 2013 Sep; 45(3):467-77. PubMed ID: 23786779
    [Abstract] [Full Text] [Related]

  • 2. Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.
    Prescrire Int; 2013 Jun; 22(139):155-9. PubMed ID: 23866358
    [Abstract] [Full Text] [Related]

  • 3. Review of recently approved alternatives to anticoagulation with warfarin for emergency clinicians.
    Brem E, Koyfman A, Foran M.
    J Emerg Med; 2013 Jul; 45(1):143-9. PubMed ID: 23375217
    [Abstract] [Full Text] [Related]

  • 4. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
    Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P, Working Group on Perioperative Haemostasis.
    Arch Cardiovasc Dis; 2013 Jul; 106(6-7):382-93. PubMed ID: 23810130
    [Abstract] [Full Text] [Related]

  • 5. [Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013].
    Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P.
    Ann Fr Anesth Reanim; 2013 Oct; 32(10):691-700. PubMed ID: 23993157
    [Abstract] [Full Text] [Related]

  • 6. Managing new oral anticoagulants in the perioperative and intensive care unit setting.
    Levy JH, Faraoni D, Spring JL, Douketis JD, Samama CM.
    Anesthesiology; 2013 Jun; 118(6):1466-74. PubMed ID: 23416382
    [Abstract] [Full Text] [Related]

  • 7. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S, Ansell J.
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [Abstract] [Full Text] [Related]

  • 8. Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban.
    Fawole A, Daw HA, Crowther MA.
    Cleve Clin J Med; 2013 Jul; 80(7):443-51. PubMed ID: 23821689
    [Abstract] [Full Text] [Related]

  • 9. The gap between trial data and clinical practice -- an analysis of case reports on bleeding complications occurring under dabigatran and rivaroxaban anticoagulation.
    Pfeilschifter W, Luger S, Brunkhorst R, Lindhoff-Last E, Foerch C.
    Cerebrovasc Dis; 2013 Jul; 36(2):115-9. PubMed ID: 24029592
    [Abstract] [Full Text] [Related]

  • 10. New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications.
    Fenger-Eriksen C, Münster AM, Grove EL.
    Acta Anaesthesiol Scand; 2014 Jul; 58(6):651-9. PubMed ID: 24716468
    [Abstract] [Full Text] [Related]

  • 11. Rivaroxaban and atrial fibrillation: continue to use warfarin or in some cases, dabigatran.
    Prescrire Int; 2012 Nov; 21(132):257-60. PubMed ID: 23210252
    [Abstract] [Full Text] [Related]

  • 12. Bleeding and antidotes in new oral anticoagulants.
    Majeed A, Schulman S.
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):191-202. PubMed ID: 23953907
    [Abstract] [Full Text] [Related]

  • 13. New oral anticoagulants: an emergency department overview.
    Wood P.
    Emerg Med Australas; 2013 Dec; 25(6):503-14. PubMed ID: 24224462
    [Abstract] [Full Text] [Related]

  • 14. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
    Assiri A, Al-Majzoub O, Kanaan AO, Donovan JL, Silva M.
    Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607
    [Abstract] [Full Text] [Related]

  • 15. Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study.
    Chang HY, Zhou M, Tang W, Alexander GC, Singh S.
    BMJ; 2015 Apr 24; 350():h1585. PubMed ID: 25911526
    [Abstract] [Full Text] [Related]

  • 16. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ.
    Postgrad Med; 2012 Nov 24; 124(6):7-16. PubMed ID: 23322134
    [Abstract] [Full Text] [Related]

  • 17. Strategies for urgent reversal of target-specific oral anticoagulants.
    Davis EM, Uhlmeyer EM, Schmidt DP, Schardt GL.
    Hosp Pract (1995); 2014 Dec 24; 42(5):108-25. PubMed ID: 25485923
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Practical considerations in emergency management of bleeding in the setting of target-specific oral anticoagulants.
    Miller MP, Trujillo TC, Nordenholz KE.
    Am J Emerg Med; 2014 Apr 24; 32(4):375-82. PubMed ID: 24512886
    [Abstract] [Full Text] [Related]

  • 20. Acute management of bleeding in patients on novel oral anticoagulants.
    Siegal DM, Crowther MA.
    Eur Heart J; 2013 Feb 24; 34(7):489-498b. PubMed ID: 23220847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.